Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.6.0.2
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock-Based Compensation Expense
The following is a summary of stock-based compensation expense recorded by the Company during the respective periods:
  
Year Ended December 31,
 
2016
 
2015
 
2014
 
(in thousands)
Selling, general and administrative expenses
$
15,687

 
$
16,380

 
$
21,204

Corporate expenses
17,036

 
16,981

 
17,825

Total
$
32,723

 
$
33,361

 
$
39,029

Assumptions Used to Calculate Fair Value of Options
The following assumptions were used to calculate the fair value of the Company’s options on the date of grant:
 
 
Year Ended December 31,
 
2016
 
2015
 
2014
Risk-free interest rate
1.24% - 1.49%

 
1.47% - 1.75%

 
1.67% - 2.00%

Dividend yield
0.0
%
 
0.0
%
 
0.0
%
Volatility factors
29.42% - 36.11%

 
34.18% - 43.36%

 
42.41% - 47.00%

Weighted average expected life (in years)
5.76

 
5.94

 
6.06

Summary of Stock Options Activity
The following table presents a summary of the Company’s stock options outstanding at, and stock option activity (“Price” reflects the weighted average exercise price per share):
 
 
Year Ended December 31,
 
2016
 
2015
 
2014
 
    Options     
 
 
    Price     
 
 
    Options     
 
 
    Price     
 
 
    Options     
 
 
    Price     
 
 
(in thousands, except per share data)
Outstanding January 1
16,309

 
$
13.54

 
16,999

 
$
13.78

 
16,628

 
$
12.68

Granted
1,103

 
19.53

 
1,667

 
25.32

 
2,345

 
21.03

Exercised
(1,063
)
 
19.10

 
(1,098
)
 
14.50

 
(1,769
)
 
12.32

Forfeited or expired
(66
)
 
22.39

 
(1,259
)
 
31.58

 
(205
)
 
19.58

Outstanding December 31
16,283

 
$
13.55

 
16,309

 
$
13.54

 
16,999

 
$
13.78

 
 
 
 
 
 
 
 
 
 
 
 
Exercisable December 31
12,628

 
$
12.01

 
11,177

 
$
11.54

 
10,669

 
$
13.68

Weighted average fair value per option granted
 
 
$
6.98

 
 
 
$
9.93

 
 

 
$
9.82

Summary of Stock Options, by Range of Exercise Prices
Vesting dates on the stock options range from March 2017 to October 2020, and expiration dates range from February 2017 to October 2026 at exercise prices and average contractual lives as follows:  
Range of
Exercise
Prices
 
Outstanding
as of
12/31/16
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price 
 
Exercisable
as of
12/31/16
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
 
 
(in thousands) 
 
(in years) 
 
 
 
(in thousands) 
 
(in years) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$2.75 - $4.99
 
2,228

 
2.2
 
$
2.84

 
2,228

 
2.2
 
$
2.84

$5.00 - $9.99
 
4,757

 
5.8
 
$
8.81

 
3,917

 
5.7
 
$
8.82

$10.00 - $14.99
 
3,108

 
4.1
 
$
11.40

 
3,108

 
4.1
 
$
11.40

$15.00 - $19.99
 
1,582

 
7.0
 
$
19.05

 
466

 
2.3
 
$
18.38

$20.00 - $24.99
 
3,030

 
5.4
 
$
22.03

 
2,267

 
4.8
 
$
22.29

$25.00 - $29.99
 
1,578

 
8.1
 
$
25.37

 
642

 
8.1
 
$
25.34

Summary of Unvested Restricted Stock Activity
The following table presents a summary of the Company’s unvested restricted stock awards outstanding at December 31, 2016, 2015 and 2014 (“Price” reflects the weighted average share price at the date of grant):
 
 
Restricted Stock 
 
Awards
 
Price
 
(in thousands, except per share data)
Unvested at December 31, 2013
2,210

 
$
10.68

Granted
752

 
21.64

Forfeited
(237
)
 
12.64

Vested
(1,554
)
 
11.50

Unvested at December 31, 2014
1,171

 
$
16.18

Granted
456

 
26.11

Forfeited
(6
)
 
10.02

Vested
(760
)
 
14.74

Unvested at December 31, 2015
861

 
$
22.67

Granted
751

 
20.65

Forfeited
(50
)
 
21.63

Vested
(482
)
 
21.73

Unvested at December 31, 2016
1,080

 
$
21.67